bahraz's library 45 articles Export Sort

Hide details

	Regulation and mechanisms of macrophage cholesterol efflux. [My Copy] J Clin Invest, Vol. 110, No. 7. (October 2002), pp. 899-904. by A. R. Tall, P. Costet, N. Wang posted to cholesterol efflux macrophage by bahraz on 2006-12-19 19:14:52 as
	Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. [My Copy] FEBS Lett, Vol. 580, No. 23. (9 October 2006), pp. 5588-5596. by M. Pennings, I. Meurs, D. Ye, et al.R. Out, M. Hoekstra, T. J. Van Berkel, M. Van Eck posted to cholesterol efflux macrophage by bahraz on 2006-12-19 19:12:54 as
	Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. [My Copy] Annu Rev Biochem, Vol. 52 (1983), pp. 223-261. by M. S. Brown, J. L. Goldstein posted to apoe by bahraz on 2006-12-19 19:09:02 as
	Role of cytokines in the pathogenesis of the euthyroid sick syndrome. [My Copy] Eur J Endocrinol, Vol. 138, No. 6. (June 1998), pp. 603-614. by L. Bartalena, F. Bogazzi, S. Brogioni, L. Grasso, E. Martino posted to endocrine infection by bahraz on 2006-12-18 21:07:46 as
	The endocrine system during sepsis. [My Copy] Am J Med Sci, Vol. 328, No. 4. (October 2004), pp. 238-247. by S. Brierre, R. Kumari, B. P. Deboisblanc posted to endocrine infection by bahraz on 2006-12-18 21:04:54 as
	Evidence for changes in adrenal and testicular steroids during HIV infection. [My Copy] J Acquir Immune Defic Syndr, Vol. 5, No. 8. (1992), pp. 841-846. by N. Christeff, S. Gharakhanian, N. Thobie, W. Rozenbaum, E. A. Nunez posted to endocrine infection by bahraz on 2006-12-18 20:57:42 as
	Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. [My Copy] Nat Med, Vol. 7, No. 6. (June 2001), pp. 699-705. by L. Makowski, J. B. Boord, K. Maeda, et al.V. R. Babaev, K. T. Uysal, M. A. Morgan, R. A. Parker, J. Suttles, S. Fazio, G. S. Hotamisligil, M. F. Linton posted to ap2 macrophages by bahraz on 2006-12-08 02:40:21 as
	Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. [My Copy] Circulation, Vol. 102, No. 15. (10 October 2000), pp. 1755-1760. by J. B. Muhlestein, J. L. Anderson, J. F. Carlquist, et al.K. Salunkhe, B. D. Horne, R. R. Pearson, T. J. Bunch, A. Allen, S. Trehan, C. Nielson posted to x-talk by bahraz on 2006-12-03 21:49:45 as
	Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. [My Copy] Lancet, Vol. 350, No. 9075. (9 August 1997), pp. 404-407. by E. Gurfinkel, G. Bozovich, A. Daroca, E. Beck, B. Mautner posted to x-talk by bahraz on 2006-12-03 21:48:03 as
	Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. [My Copy] Circulation, Vol. 97, No. 7. (24 February 1998), pp. 633-636. by J. B. Muhlestein, J. L. Anderson, E. H. Hammond, et al.L. Zhao, S. Trehan, E. P. Schwobe, J. F. Carlquist posted to x-talk by bahraz on 2006-12-03 21:46:18 as
	The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. [My Copy] J Clin Invest, Vol. 103, No. 5. (March 1999), pp. 747-753. by H. Hu, G. N. Pierce, G. Zhong posted to x-talk by bahraz on 2006-12-03 21:43:45 as
	Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. [My Copy] Pathol Int, Vol. 52, No. 12. (December 2002), pp. 755-763. by Y. Shi, O. Tokunaga posted to x-talk by bahraz on 2006-12-03 21:37:36 as
	Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. [My Copy] Circulation, Vol. 92, No. 12. (15 December 1995), pp. 3397-3400. by J. T. Grayston, C. C. Kuo, A. S. Coulson, et al.L. A. Campbell, R. D. Lawrence, M. J. Lee, E. D. Strandness, S. P. Wang posted to x-talk by bahraz on 2006-12-03 21:36:09 as
	Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. [My Copy] J Med Virol, Vol. 42, No. 2. (February 1994), pp. 170-174. by J. L. Melnick, C. Hu, J. Burek, E. Adam, M. E. DeBakey posted to x-talk by bahraz on 2006-12-03 21:24:19 as
	High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. [My Copy] Am J Pathol, Vol. 136, No. 1. (January 1990), pp. 23-28. by M. G. Hendrix, M. M. Salimans, C. P. van Boven, C. A. Bruggeman posted to x-talk by bahraz on 2006-12-03 21:23:11 as
	Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. [My Copy] J Infect Dis, Vol. 155, No. 1. (January 1987), pp. 158-159. by B. L. Petrie, J. L. Melnick, E. Adam, J. Burek, C. H. McCollum, M. E. DeBakey posted to x-talk by bahraz on 2006-12-03 21:20:36 as
	Cytomegalovirus antigen within human arterial smooth muscle cells. [My Copy] Lancet, Vol. 2, No. 8351. (17 September 1983), pp. 644-647. by J. L. Melnick, B. L. Petrie, G. R. Dreesman, J. Burek, C. H. McCollum, M. E. DeBakey posted to x-talk by bahraz on 2006-12-03 21:19:09 as
	Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. [My Copy] Am Heart J, Vol. 142, No. 4. (October 2001), pp. 633-640. by M. Gattone, L. Iacoviello, M. Colombo, et al.A. D. Castelnuovo, F. Soffiantino, A. Gramoni, D. Picco, M. Benedetta, P. Giannuzzi posted to x-talk by bahraz on 2006-12-03 21:15:56 as
	Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. [My Copy] Hepatology, Vol. 33, No. 6. (June 2001), pp. 1358-1364. by L. E. Adinolfi, M. Gambardella, A. Andreana, M. F. Tripodi , R. Utili, G. Ruggiero posted to x-talk by bahraz on 2006-12-01 19:25:54 as
	Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. [My Copy] Gut, Vol. 52, No. 2. (February 2003), pp. 288-292. by L. Castéra, C. Hézode, F. Roudot-Thoraval, et al.A. Bastie, E. S. Zafrani, J. M. Pawlotsky, D. Dhumeaux posted to x-talk by bahraz on 2006-12-01 19:23:36 as
	The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. [My Copy] J Hepatol, Vol. 40, No. 3. (March 2004), pp. 484-490. by H. M. Patton, K. Patel, C. Behling, et al.D. Bylund, L. M. Blatt, M. Vallée, S. Heaton, A. Conrad, P. J. Pockros, J. G. McHutchison posted to x-talk by bahraz on 2006-12-01 19:22:07 as
	Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. [My Copy] Science, Vol. 289, No. 5484. (1 September 2000), pp. 1524-1529. by J. J. Repa, S. D. Turley, J. A. Lobaccaro, et al.J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, D. J. Mangelsdorf posted to must read by bahraz on 2006-12-01 19:03:46 as
	Type I interferons in host defense. [My Copy] Immunity, Vol. 25, No. 3. (September 2006), pp. 373-381. by D. B. Stetson, R. Medzhitov posted to x-talk by bahraz on 2006-12-01 18:46:24 as along with 1 person Pezda
	Pathogen recognition and innate immunity. [My Copy] Cell, Vol. 124, No. 4. (24 February 2006), pp. 783-801. by S. Akira, S. Uematsu, O. Takeuchi posted to x-talk by bahraz on 2006-12-01 18:45:16 as along with 4 people lwitbr AlfonsoVicenteSuarez thefillm Pezda
	Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. [My Copy] Lancet, Vol. 349, No. 9055. (22 March 1997), pp. 825-832. by T. Poynard, P. Bedossa, P. Opolon posted to x-talk by bahraz on 2006-12-01 03:24:04 as
	The pathology of hepatitis C. [My Copy] Hepatology, Vol. 15, No. 4. (April 1992), pp. 567-571. by P. J. Scheuer, P. Ashrafzadeh, S. Sherlock, D. Brown, G. M. Dusheiko posted to x-talk by bahraz on 2006-12-01 03:21:24 as
	Body composition and hepatic steatosis as precursors for fibrotic liver disease. [My Copy] Hepatology, Vol. 29, No. 4. (April 1999), pp. 1328-1330. by A. J. McCullough, Y. Falck-Ytter posted to x-talk by bahraz on 2006-12-01 03:19:32 as
	Public Health Service study of Reye's syndrome and medications. Report of the main study. [My Copy] JAMA, Vol. 257, No. 14. (10 April 1987), pp. 1905-1911. by E. S. Hurwitz, M. J. Barrett, D. Bregman, et al.W. J. Gunn, P. Pinsky, L. B. Schonberger, J. S. Drage, R. A. Kaslow, D. B. Burlington, G. V. Quinnan posted to x-talk by bahraz on 2006-12-01 03:12:39 as
	Aspirin as a risk factor in Reye's syndrome. [My Copy] JAMA, Vol. 247, No. 22. (11 June 1982), pp. 3089-3094. by R. J. Waldman, W. N. Hall, H. McGee, G. Van Amburg posted to x-talk by bahraz on 2006-12-01 03:11:32 as
	Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. [My Copy] Gastroenterology, Vol. 130, No. 6. (May 2006), pp. 1636-1642. by G. Leandro, A. Mangia, J. Hui, et al.P. Fabris, L. Rubbia-Brandt, G. Colloredo, L. E. Adinolfi, T. Asselah, J. R. Jonsson, A. Smedile, N. Terrault, V. Pazienza, M. T. Giordani, E. Giostra, A. Sonzogni, G. Ruggiero, P. Marcellin, E. E. Powell, J. George, F. Negro, posted to x-talk by bahraz on 2006-11-30 22:01:50 as
	Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. [My Copy] Hepatology, Vol. 29, No. 4. (April 1999), pp. 1215-1219. by L. F. Hourigan, G. A. Macdonald, D. Purdie, et al.V. H. Whitehall, C. Shorthouse, A. Clouston, E. E. Powell posted to x-talk by bahraz on 2006-11-30 21:44:39 as
	Aspirin and Reye's syndrome: is the response appropriate? [My Copy] J Clin Pharm Ther, Vol. 27, No. 3. (June 2002), pp. 157-160. by N. J. Langford posted to x-talk by bahraz on 2006-11-29 08:04:10 as
	Reye's syndrome in the United States from 1981 through 1997. [My Copy] N Engl J Med, Vol. 340, No. 18. (6 May 1999), pp. 1377-1382. by E. D. Belay, J. S. Bresee, R. C. Holman, A. S. Khan, A. Shahriari, L. B. Schonberger posted to x-talk by bahraz on 2006-11-29 00:54:35 as
	Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? [My Copy] Nat Rev Microbiol, Vol. 2, No. 1. (January 2004), pp. 23-32. by L. A. Campbell, C. C. Kuo posted to x-talk by bahraz on 2006-11-28 21:32:17 as
	Chlamydia pneumoniae and atherosclerosis. [My Copy] Cell Microbiol, Vol. 6, No. 2. (February 2004), pp. 117-127. by R. J. Belland, S. P. Ouellette, J. Gieffers, G. I. Byrne posted to x-talk by bahraz on 2006-11-28 21:08:31 as
	Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. [My Copy] Atherosclerosis, Vol. 181, No. 1. (July 2005), pp. 39-44. by I. Vliegen, S. B. Herngreen, G. E. Grauls, C. A. Bruggeman, F. R. Stassen posted to x-talk by bahraz on 2006-11-28 19:39:02 as
	Chlamydia pneumoniae and vascular disease: an update. [My Copy] J Vasc Surg, Vol. 43, No. 6. (June 2006), pp. 1301-1307. by F. F. Mussa, H. Chai, X. Wang, Q. Yao, A. B. Lumsden, C. Chen posted to x-talk by bahraz on 2006-11-28 19:18:34 as
	Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. [My Copy] Mol Cell, Vol. 12, No. 4. (October 2003), pp. 805-816. by A. Castrillo, S. B. Joseph, S. A. Vaidya, et al.M. Haberland, A. M. Fogelman, G. Cheng, P. Tontonoz posted to x-talk by bahraz on 2006-11-28 04:42:30 as
	High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. [My Copy] Am J Cardiol, Vol. 81, No. 7. (1 April 1998), pp. 866-868. by A. Blum, M. Giladi, M. Weinberg, et al.G. Kaplan, H. Pasternack, S. Laniado, H. Miller posted to x-talk by bahraz on 2006-11-28 04:38:43 as
	Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. [My Copy] BMJ, Vol. 321, No. 7255. (22 July 2000), pp. 208-213. by J. Danesh, P. Whincup, M. Walker, et al.L. Lennon, A. Thomson, P. Appleby, Y. Wong, M. Bernardes-Silva, M. Ward posted to x-talk by bahraz on 2006-11-28 04:36:13 as
	Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. [My Copy] Eur Heart J, Vol. 23, No. 5. (March 2002), pp. 371-375. by J. Danesh, P. Whincup, S. Lewington, et al.M. Walker, L. Lennon, A. Thomson, Y. K. Wong, X. Zhou, M. Ward posted to x-talk by bahraz on 2006-11-28 04:33:48 as
	Chronic infections and coronary heart disease: is there a link? [My Copy] Lancet, Vol. 350, No. 9075. (9 August 1997), pp. 430-436. by J. Danesh, R. Collins, R. Peto posted to x-talk by bahraz on 2006-11-28 04:27:50 as
	Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. [My Copy] JAMA, Vol. 288, No. 21. (4 December 2002), pp. 2724-2731. by M. V. Kalayoglu, P. Libby, G. I. Byrne posted to x-talk by bahraz on 2006-11-28 04:22:44 as
	Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. [My Copy] Lancet, Vol. 2, No. 8618. (29 October 1988), pp. 983-986. by P. Saikku, M. Leinonen, K. Mattila, et al.M. R. Ekman, M. S. Nieminen, P. H. Mäkelä, J. K. Huttunen, V. Valtonen posted to x-talk by bahraz on 2006-11-28 04:18:33 as
	Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. [My Copy] Circulation, Vol. 94, No. 5. (1 September 1996), pp. 922-927. by F. J. Nieto, E. Adam, P. Sorlie, et al.H. Farzadegan, J. L. Melnick, G. W. Comstock, M. Szklo posted to cross-talk immune-metabolic by bahraz on 2006-11-28 04:16:12 as